Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 9 | 2025 | 669 | 2.830 |
Why?
|
| Neurology | 5 | 2025 | 112 | 2.370 |
Why?
|
| Neurophysiological Monitoring | 3 | 2024 | 35 | 1.190 |
Why?
|
| Rhizomucor | 1 | 2025 | 5 | 0.930 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2025 | 13 | 0.910 |
Why?
|
| Mucormycosis | 1 | 2025 | 31 | 0.890 |
Why?
|
| Nervous System Diseases | 3 | 2024 | 394 | 0.880 |
Why?
|
| Pediatrics | 4 | 2025 | 1205 | 0.680 |
Why?
|
| Status Epilepticus | 2 | 2022 | 151 | 0.680 |
Why?
|
| Spinal Cord Injuries | 1 | 2024 | 274 | 0.670 |
Why?
|
| Clinical Protocols | 1 | 2021 | 227 | 0.650 |
Why?
|
| Brain Injuries | 2 | 2023 | 693 | 0.620 |
Why?
|
| GABA Modulators | 1 | 2018 | 11 | 0.590 |
Why?
|
| Pentobarbital | 1 | 2018 | 20 | 0.580 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 630 | 0.540 |
Why?
|
| Stroke | 1 | 2025 | 1028 | 0.520 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 248 | 0.460 |
Why?
|
| Electroencephalography | 4 | 2023 | 822 | 0.450 |
Why?
|
| Child | 17 | 2025 | 25296 | 0.430 |
Why?
|
| Immunocompromised Host | 2 | 2025 | 303 | 0.320 |
Why?
|
| Brain | 1 | 2021 | 3039 | 0.310 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2021 | 472 | 0.280 |
Why?
|
| Clinical Competence | 2 | 2025 | 1020 | 0.250 |
Why?
|
| Humans | 19 | 2025 | 127321 | 0.230 |
Why?
|
| Competency-Based Education | 1 | 2025 | 68 | 0.220 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2024 | 33 | 0.210 |
Why?
|
| Common Data Elements | 1 | 2023 | 6 | 0.210 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2024 | 77 | 0.200 |
Why?
|
| Hospitals, Pediatric | 3 | 2022 | 775 | 0.200 |
Why?
|
| Curriculum | 2 | 2025 | 766 | 0.190 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2024 | 200 | 0.190 |
Why?
|
| Monitoring, Physiologic | 2 | 2022 | 371 | 0.190 |
Why?
|
| Patient Discharge | 2 | 2022 | 495 | 0.170 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2020 | 10 | 0.160 |
Why?
|
| Education, Medical, Graduate | 2 | 2023 | 533 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 315 | 0.160 |
Why?
|
| Sodium Channel Blockers | 1 | 2018 | 22 | 0.140 |
Why?
|
| Phenytoin | 1 | 2018 | 57 | 0.140 |
Why?
|
| Hospitalization | 2 | 2024 | 1880 | 0.140 |
Why?
|
| Quality of Health Care | 1 | 2021 | 400 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2023 | 534 | 0.140 |
Why?
|
| Critical Illness | 1 | 2022 | 604 | 0.140 |
Why?
|
| Adolescent | 4 | 2025 | 20150 | 0.130 |
Why?
|
| Inpatients | 1 | 2021 | 540 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 137 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 413 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1047 | 0.100 |
Why?
|
| Seizures | 1 | 2018 | 847 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 5150 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 549 | 0.090 |
Why?
|
| North America | 2 | 2023 | 250 | 0.090 |
Why?
|
| Infant | 3 | 2024 | 12806 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 1168 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2024 | 14462 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 3934 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17066 | 0.080 |
Why?
|
| Focus Groups | 1 | 2025 | 216 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2025 | 240 | 0.050 |
Why?
|
| United States | 3 | 2025 | 11385 | 0.050 |
Why?
|
| Consciousness Disorders | 1 | 2023 | 26 | 0.050 |
Why?
|
| Coma | 1 | 2023 | 55 | 0.050 |
Why?
|
| Consciousness | 1 | 2023 | 46 | 0.050 |
Why?
|
| Male | 4 | 2024 | 62788 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2021 | 110 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 283 | 0.040 |
Why?
|
| Intracranial Pressure | 1 | 2021 | 200 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 428 | 0.040 |
Why?
|
| Female | 3 | 2024 | 68630 | 0.040 |
Why?
|
| Drug Evaluation | 1 | 2018 | 102 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2023 | 8365 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2018 | 240 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 359 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 2995 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 754 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1142 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1597 | 0.030 |
Why?
|
| Gestational Age | 1 | 2018 | 1188 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6241 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1177 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 12572 | 0.010 |
Why?
|